利伐沙班进医保了吗

(Rivaroxaban) is the world's first oral direct factor XA inhibitor. Compared with traditional anticoagulants, it is more effective, does not require constant monitoring, has good safety and is easy to use. It is expected to become an alternative drug to heparin and vitamin K antagonists. The drug was approved by the National Medical Products Administration for marketing in China in 2009. In the same year, rivaroxaban was also included in the national medical insurance catalog, which relieved a certain burden on the treatment of many domestic patients.

However, many patients are still unable to afford the drugs after medical insurance, especially for those families who need long-term treatment with Rivaroxaban and have limited financial resources, which will inevitably bring a heavy burden. How to find more cost-effective drugs has become one of the issues that patients are currently concerned about.

According to Medical Travel, a box of rivaroxaban (Xarelto) sold abroad is priced at about $170 for 10mg*28 pills, about $500 for 15mg*28 pills, and about $600 for 20mg*28 pills. The price is relatively cheap and within the reach of most patients. In this regard, patients in need can contact some professional and reliable overseas medical service organizations in China (such as Medical Companion Travel) to obtain purchase channels for the required drugs. Since exchange rate fluctuations will cause price changes, you need to consult Medical Travel for specific prices. 

After purchasing the medicine, due to the different indications and drug specifications, patients must strictly follow the doctor's instructions or use the medicine according to the instructions when actually using it (i.e. Xarelto) for treatment. Otherwise, the efficacy of the medicine may be reduced, and it may even lead to the occurrence of some unsafe incidents, endangering the patient's own health and life safety.

Recommended hot articles: /newsDetail/73135.html